X4 Pharmaceuticals Inc.

NASDAQ: XFOR · Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.85
0.35%
After-hours: Aug 15, 2025, 04:10 PM EDT

X4 Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.56M n/a n/a n/a
Cost of Revenue
797K 2M 1.99M 1.89M
Gross Profit
1.76M -2M -1.99M -1.89M
Operating Income
-36.4M -107.52M -87.57M -85.11M
Interest Income
5.77M 4.58M 219K 10K
Pretax Income
-37.14M -101.09M -93.84M -88.68M
Net Income
-37.45M -101.17M -93.87M -88.7M
Selling & General & Admin
61.52M 35.51M 27.02M 24.7M
Research & Development
81.64M 72.02M 61.06M 50.65M
Other Expenses
-105M n/a -509K 9.76M
Operating Expenses
38.16M 107.52M 87.57M 85.11M
Interest Expense
8.77M 5.78M 3.99M 3.64M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
38.96M 107.52M 87.57M 85.11M
Income Tax Expense
310K 78K 28K 17K
Shares Outstanding (Basic)
6.7M 5.93M 2.06M 741.7K
Shares Outstanding (Diluted)
6.7M 5.93M 2.12M 858.29K
EPS (Basic)
-5.7 -17.1 -45.6 -119.7
EPS (Diluted)
-5.7 -17.1 -45.6 -119.7
EBITDA
-27.58M -107.1M -87.57M -84.54M
EBIT
-28.37M -107.52M -89.85M -85.04M
Depreciation & Amortization
796K 419K 1.99M 499K